166 related articles for article (PubMed ID: 28229405)
1. Compact Bone-Derived Multipotent Mesenchymal Stromal Cells (MSCs) for the Treatment of Sjogren's-like Disease in NOD Mice.
Elghanam GA; Liu Y; Khalili S; Fang D; Tran SD
Methods Mol Biol; 2017; 1553():25-39. PubMed ID: 28229405
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.
Xu J; Wang D; Liu D; Fan Z; Zhang H; Liu O; Ding G; Gao R; Zhang C; Ding Y; Bromberg JS; Chen W; Sun L; Wang S
Blood; 2012 Oct; 120(15):3142-51. PubMed ID: 22927248
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
Zou Y; Xiao W; Liu D; Li X; Li L; Peng L; Xiong Y; Gan H; Ren X
Immun Inflamm Dis; 2024 Jan; 12(1):e1139. PubMed ID: 38270310
[TBL] [Abstract][Full Text] [Related]
7. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
Li B; Xing Y; Gan Y; He J; Hua H
Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review.
Chihaby N; Orliaguet M; Le Pottier L; Pers JO; Boisramé S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638813
[TBL] [Abstract][Full Text] [Related]
9. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
11. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
Huang K; Zhou DH; Huang SL; Liang SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Derived from Human Bone Marrow.
Gardner OF; Alini M; Stoddart MJ
Methods Mol Biol; 2015; 1340():41-52. PubMed ID: 26445829
[TBL] [Abstract][Full Text] [Related]
13. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
Kaibuchi N; Iwata T; Yamato M; Okano T; Ando T
Acta Biomater; 2016 Sep; 42():400-410. PubMed ID: 27326918
[TBL] [Abstract][Full Text] [Related]
14. Treatment for salivary gland hypofunction at both initial and advanced stages of Sjögren-like disease: a comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period.
Khalili S; Faustman DL; Liu Y; Sumita Y; Blank D; Peterson A; Kodama S; Tran SD
Cytotherapy; 2014 Mar; 16(3):412-23. PubMed ID: 24411591
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of mesenchymal stem cells.
Odabas S; Elçin AE; Elçin YM
Methods Mol Biol; 2014; 1109():47-63. PubMed ID: 24473777
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use.
Peltzer J; Montespan F; Thepenier C; Boutin L; Uzan G; Rouas-Freiss N; Lataillade JJ
Stem Cells Dev; 2015 Feb; 24(3):329-44. PubMed ID: 25203666
[TBL] [Abstract][Full Text] [Related]
17. Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
Tran SD; Kodama S; Lodde BM; Szalayova I; Key S; Khalili S; Faustman DL; Mezey E
Ann Rheum Dis; 2007 Jun; 66(6):812-4. PubMed ID: 17179174
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
[No Abstract] [Full Text] [Related]
19. Comparative characterization of mesenchymal stromal cells from multiple abdominal adipose tissues and enrichment of angiogenic ability via CD146 molecule.
Lee NE; Kim SJ; Yang SJ; Joo SY; Park H; Lee KW; Yang HM; Park JB
Cytotherapy; 2017 Feb; 19(2):170-180. PubMed ID: 28024875
[TBL] [Abstract][Full Text] [Related]
20. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
